Back to Search
JUDY LAM, PH.D.
PH.D.
Clinical Psychologist
NPI: 1831131945IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
PSY 16908(CA)PSY 202366(ID)
CMS Specialties
PrimaryCLINICAL PSYCHOLOGIST
Education
OTHER
Class of 1994
Research & Publications (20)
Importance of surgical margins in the management of renal cell carcinoma.
PMID 18477995·Nat Clin Pract Urol·2008
6-review
Prognostic factors and selection for clinical studies of patients with kidney cancer.
PMID 17931881·Crit Rev Oncol Hematol·2008
6-review
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience.
PMID 17316970·Eur Urol·2007
4-observational
Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials.
PMID 17255297·Clin Cancer Res·2007
6-review
Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.
PMID 17158542·J Clin Oncol·2006
6-review
Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score.
PMID 16879693·BJU Int·2006
8-other
Long-term outcomes of the surgical management of renal cell carcinoma.
PMID 16479388·World J Urol·2006
6-review
Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.
PMID 16194700·Urology·2005
6-review
Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.
PMID 16104896·BJU Int·2005
6-review
Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
PMID 16006866·J Urol·2005
8-other
Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
PMID 15880379·Cancer·2005
8-other
Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
PMID 15879764·J Urol·2005
6-review
Prostate stem cell antigen is overexpressed in prostate cancer metastases.
PMID 15814638·Clin Cancer Res·2005
4-observational
Novel approaches in the therapy of metastatic renal cell carcinoma.
PMID 15812574·World J Urol·2005
6-review
Surveillance following radical or partial nephrectomy for renal cell carcinoma.
PMID 15610692·Curr Urol Rep·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2409 N 21ST ST
BOISE, ID 83702 - Phone
- (208) 283-0628
Quick Facts
- NPI
- 1831131945
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile